Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Endocrine Peptides Test Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Endocrine Peptides Test Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Estradiol (E2)
      • 1.3.3 Dehydroepiandrosterone Sulfate (DHEAS)
      • 1.3.4 Human Chorionic Gonadotropin (hCG)
      • 1.3.5 Progesterone, Luteinizing Hormone (LH)
      • 1.3.6 Thyroid Stimulating Hormone (TSH)
      • 1.3.7 Thyroid Prolactin
      • 1.3.8 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Endocrine Peptides Test Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Physicians’ offices
      • 1.4.4 Commercial Laboratories
      • 1.4.5 Health Care Centers
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Endocrine Peptides Test Production Value 2014-2025
      • 2.1.2 Global Endocrine Peptides Test Production 2014-2025
      • 2.1.3 Global Endocrine Peptides Test Capacity 2014-2025
      • 2.1.4 Global Endocrine Peptides Test Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Endocrine Peptides Test Market Size CAGR of Key Regions
      • 2.2.2 Global Endocrine Peptides Test Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Endocrine Peptides Test Capacity by Manufacturers
      • 3.1.2 Global Endocrine Peptides Test Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Endocrine Peptides Test Revenue by Manufacturers (2014-2019)
      • 3.2.2 Endocrine Peptides Test Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Endocrine Peptides Test Market Concentration Ratio (CR5 and HHI)
    • 3.3 Endocrine Peptides Test Price by Manufacturers
    • 3.4 Key Manufacturers Endocrine Peptides Test Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Endocrine Peptides Test Market
    • 3.6 Key Manufacturers Endocrine Peptides Test Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Estradiol (E2) Production and Production Value (2014-2019)
      • 4.1.2 Dehydroepiandrosterone Sulfate (DHEAS) Production and Production Value (2014-2019)
      • 4.1.3 Human Chorionic Gonadotropin (hCG) Production and Production Value (2014-2019)
      • 4.1.4 Progesterone, Luteinizing Hormone (LH) Production and Production Value (2014-2019)
      • 4.1.5 Thyroid Stimulating Hormone (TSH) Production and Production Value (2014-2019)
      • 4.1.6 Thyroid Prolactin Production and Production Value (2014-2019)
      • 4.1.7 Others Production and Production Value (2014-2019)
    • 4.2 Global Endocrine Peptides Test Production Market Share by Type
    • 4.3 Global Endocrine Peptides Test Production Value Market Share by Type
    • 4.4 Endocrine Peptides Test Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Endocrine Peptides Test Consumption by Application

    6 Production by Regions

    • 6.1 Global Endocrine Peptides Test Production (History Data) by Regions 2014-2019
    • 6.2 Global Endocrine Peptides Test Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Endocrine Peptides Test Production Growth Rate 2014-2019
      • 6.3.2 United States Endocrine Peptides Test Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Endocrine Peptides Test Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Endocrine Peptides Test Production Growth Rate 2014-2019
      • 6.4.2 European Union Endocrine Peptides Test Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Endocrine Peptides Test Import & Export
    • 6.5 China
      • 6.5.1 China Endocrine Peptides Test Production Growth Rate 2014-2019
      • 6.5.2 China Endocrine Peptides Test Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Endocrine Peptides Test Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Endocrine Peptides Test Consumption by Regions

    • 7.1 Global Endocrine Peptides Test Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Endocrine Peptides Test Consumption by Type
      • 7.2.2 United States Endocrine Peptides Test Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Endocrine Peptides Test Consumption by Type
      • 7.3.2 European Union Endocrine Peptides Test Consumption by Application
    • 7.4 China
      • 7.4.1 China Endocrine Peptides Test Consumption by Type
      • 7.4.2 China Endocrine Peptides Test Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Endocrine Peptides Test Consumption by Type
      • 7.5.2 Rest of World Endocrine Peptides Test Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Quest Diagnostics
      • 8.1.1 Quest Diagnostics Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Endocrine Peptides Test
      • 8.1.4 Endocrine Peptides Test Product Introduction
      • 8.1.5 Quest Diagnostics Recent Development
    • 8.2 Siemens Healthcare
      • 8.2.1 Siemens Healthcare Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Endocrine Peptides Test
      • 8.2.4 Endocrine Peptides Test Product Introduction
      • 8.2.5 Siemens Healthcare Recent Development
    • 8.3 Abbott Laboratories
      • 8.3.1 Abbott Laboratories Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Endocrine Peptides Test
      • 8.3.4 Endocrine Peptides Test Product Introduction
      • 8.3.5 Abbott Laboratories Recent Development
    • 8.4 bioMerieux
      • 8.4.1 bioMerieux Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Endocrine Peptides Test
      • 8.4.4 Endocrine Peptides Test Product Introduction
      • 8.4.5 bioMerieux Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Endocrine Peptides Test Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Endocrine Peptides Test Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Endocrine Peptides Test Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Endocrine Peptides Test Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Endocrine Peptides Test Production Forecast by Type
      • 9.7.2 Global Endocrine Peptides Test Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Endocrine Peptides Test Sales Channels
      • 10.2.2 Endocrine Peptides Test Distributors
    • 10.3 Endocrine Peptides Test Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Endocrine peptide test is used for the measurement of the level of c-peptide present in the blood. C-peptide and insulin are usually found in equivalent amounts. 
      In 2019, the market size of Endocrine Peptides Test is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Endocrine Peptides Test.

      This report studies the global market size of Endocrine Peptides Test, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Endocrine Peptides Test production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Quest Diagnostics
      Siemens Healthcare
      Abbott Laboratories
      bioMerieux
      ...

      Market Segment by Product Type
      Estradiol (E2)
      Dehydroepiandrosterone Sulfate (DHEAS)
      Human Chorionic Gonadotropin (hCG)
      Progesterone, Luteinizing Hormone (LH)
      Thyroid Stimulating Hormone (TSH)
      Thyroid Prolactin
      Others

      Market Segment by Application
      Hospitals
      Physicians’ offices
      Commercial Laboratories
      Health Care Centers

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Endocrine Peptides Test status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Endocrine Peptides Test manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Endocrine Peptides Test are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now